Premier Nutraceuticals Private Limited - Due diligence report

A 360° intelligence report on Premier Nutraceuticals: trust score, financial health, credit view, compliance, directors, growth and distress…

2003-02-18 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
PN Premier Nutraceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Premier Nutraceuticals — 360° Intelligence Report

Generated from MCA filings & public records
90/100
Trust Score
Low Risk

Premier Nutraceuticals is assessed as Low Risk with a Trust Score of 90/100. Premier Nutraceuticals is an active private limited indian non-government company incorporated in 2003, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Premier Nutraceuticals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
90/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (MSE).

Charges position: 6 open (13.86 cr) · 8 satisfied (41.20 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of India5 48.0 cr
Others3 48.0 cr
Hdfc Bank Limited2 48.0 cr
Export-Import Bank Of India1 48.0 cr
Bank Of India - Dharampeth Branch1 48.0 cr
Hdfc Bank Ltd1 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (700 disclosure(s)).
  • 3 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
PRIYAMVADA ARVIND IYER 01234567 Director 01/04/2018 6 yrs Approved
ARVIND SHRINIVASAN IYER 01234567 Director 01/04/2018 6 yrs Approved
ARJUN ARVIND IYER 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: ARVIND SHRINIVASAN IYER (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
6 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 1.98 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment86/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 6 open charge(s) of 13.86 cr already registered.
  • Compliance record supports lending.
Investor view84/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
29 Jul 2025
Charge created
Bank Of India - 1.50 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Mar 2024
Share transfer (FY 2024)
100.00000000 shares to Arjun Arvind Iyer
17 Jan 2024
Charge created
Bank Of India - 2.45 cr
06 Apr 2023
Charge satisfied
Hdfc Bank Limited
27 Sep 2022
Charge created
Bank Of India - 6.27 cr
21 Jul 2022
Charge satisfied
Others
31 Jan 2022
Charge created
Bank Of India - 1.55 cr
15 Jan 2020
Charge satisfied
Bank Of India - Dharampeth Branch
05 Dec 2018
Charge created
Others - 1.06 cr
23 Mar 2018
Charge satisfied
Others
21 Feb 2018
Charge satisfied
Bank Of India
14 Feb 2018
Charge created
Others - 1.05 cr
17 Nov 2017
Charge created
Hdfc Bank Limited - 7.99 cr
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of MSE from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Ferrox Chemicals Private Limited U51900MH2008PTC186057 Mumbai, Maharashtra, India
Man Care Laboratories Private Limited U51397JH2006PTC012607 Ranchi, Jharkhand, India
Nixi Laboratories Private Limited U24100HP2016PTC001167 Nahan, Himachal Pradesh, India
Softesule Private Limited U99999MH1962PTC012409 Na, Maharashtra, India
Vedic Cosmeceuticals U24246DL2003PTC118255 New Delhi, Delhi, India
B.Jain Pharmaceuticals U24231DL2006PTC146748 Shahdara, Delhi, India
Rotech Healthcare Private Limited U17309GJ2022PTC129396 Rajkot, Gujarat, India
Voxtur Bio Limited U25190MH2012PLC238544 Taluka Vasai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Premier Nutraceuticals before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Premier Nutraceuticals: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Premier Nutraceuticals - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 90/100, distress signals and MSME payment-delay disclosures - know whether Premier Nutraceuticals pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Premier Nutraceuticals - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Premier Nutraceuticals an active company?

Premier Nutraceuticals has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Premier Nutraceuticals financially healthy?

Premier Nutraceuticals has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Premier Nutraceuticals?

Its overall Trust Score is 90/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Premier Nutraceuticals?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Premier Nutraceuticals have loans or charges against its assets?

6 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.

Is Premier Nutraceuticals up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Premier Nutraceuticals?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.